Today: 20 May 2026
Intel stock rebounds late after CFO share-buy filing; traders eye supply squeeze and the Fed
28 January 2026
1 min read

Intel stock rebounds late after CFO share-buy filing; traders eye supply squeeze and the Fed

New York, January 27, 2026, 17:34 (EST) — Trading extended into after-hours session

  • Intel shares bounced back in late Tuesday trading, clawing back some of last week’s sharp losses after its forecast
  • A regulatory filing showed that Intel’s CFO purchased shares on the open market
  • Investors are still focused on whether supply shortages will ease in the coming quarter

Intel Corp shares rose 3.4% to $43.93 in after-hours trading Tuesday, after swinging between $42.72 and $44.53 during the day. About 116 million shares changed hands.

Intel’s shares plunged 14% on Friday after its forecast missed the mark for a swift recovery. The drop came amid supply constraints limiting the company’s capacity to satisfy booming AI-related demand for data-center chips. Analysts at TD Cowen warned the recent surge was driven more by “the dream” than by actual fundamentals. Reuters

Timing couldn’t be more critical: Intel’s stock increasingly acts as a gauge for the chip cycle and U.S. manufacturing policy, just as rate forecasts pivot again. The Federal Reserve’s rate-setting panel meets January 27-28, putting tech valuations under a spotlight.

A Form 4 filing, the required insider disclosure for stock transactions, showed CFO David Zinsner bought 5,882 shares at $42.50 on Jan. 26. That raised his direct holdings to 247,392 shares.

Intel forecasted first-quarter revenue in the range of $11.7 billion to $12.7 billion last week, with adjusted earnings per share expected to break even. CFO Zinsner mentioned supply will hit its lowest point in Q1 but should improve starting in Q2. CEO Lip-Bu Tan said the company is “working aggressively to grow supply” and meet demand. Intel Corporation

Tan told analysts he was “disappointed” Intel couldn’t fully meet demand, after the company admitted it was caught off guard by a surge in data-center CPUs paired with Nvidia’s AI-powered graphics chips. Michael Schulman, CIO at Running Point Capital, called the issue “supply-constrained rather than demand-constrained.” Reuters

The tougher question is whether Intel can turn this demand into profits without squeezing its margins even more. The company has put the spotlight on its upcoming “18A” manufacturing technology—a key step for new chips—but problems with manufacturing and supply chains linger. At the same time, rivals such as AMD are pushing hard to grab market share in PCs and servers. Financial Times

U.S. stocks hit fresh highs, driven by strong earnings outlooks, even as tariff worries linger and the Fed’s decision looms. The risk appetite pulled investors back into chip stocks after last week’s volatile moves.

Insider buying isn’t a cure-all. Should supply chain problems persist into the second quarter, or if manufacturing yields and product mix keep pressuring margins, Intel’s rebound could disappear as fast as it showed up.

Wednesday wraps up the Fed’s two-day meeting, with Chair Jerome Powell scheduled to speak to reporters—a critical juncture that could move rate-sensitive tech stocks sharply.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex
Previous Story

Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex

Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision
Next Story

Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision

Go toTop